Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarpogrelate SR in Intermittent Claudication
NCT06046196Phase 4Completed
- Sponsor
- Yuhan
- Start
- Nov 2020
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sarpogrelate in intermittent claudication (IC), sponsored by Yuhan. Started Nov 2020; status: completed.
02
Drugs
sarpogrelate
03
Conditions
intermittent claudication (IC)
Beyond the preview
Go deeper on NCT06046196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06046196.